Code | CSB-RA257220A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
FC | 1:50-1:200 |
The production of the GYPA recombinant monoclonal antibody begins with the acquisition of GYPA antibody genes. These GYPA antibody genes are then introduced into appropriate host cells, which are cultured for synthesizing GYPA antibodies through a cell-based expression and translation system. This method offers several advantages, including significantly enhancing the purity and stability of the resulting GYPA recombinant monoclonal antibodies, as well as improving their affinity and specificity. Following synthesis, the GYPA recombinant monoclonal antibody undergoes a purification process using affinity chromatography. Subsequently, it undergoes testing through ELISA and FC assays. This antibody exclusively targets the human GYPA protein.
GYPA (glycophorin A) is a key component of the erythrocyte membrane with roles in maintaining membrane structure, blood group determination, mechanical resilience, and potentially cell adhesion and signaling. Its presence on the surface of red blood cells is essential for their proper function in oxygen transport and maintaining blood compatibility.
There are currently no reviews for this product.